Sep 24, 2026 09:02AM
Sep 24, 2026 09:00AM
Sep 16, 2026 09:01AM
Sep 16, 2026 09:00AM
Aug 31, 2026 09:02AM
Aug 31, 2026 09:00AM
Aug 26, 2026 09:02AM Sunshine Biopharma reports tumor suppression results with K1.1 mRNA program
Aug 26, 2026 09:00AM
Aug 19, 2026 09:02AM
Aug 19, 2026 09:00AM
Aug 7, 2026 09:00AM
Aug 4, 2026 09:02AM
Aug 4, 2026 09:00AM
Jul 28, 2026 08:04AM Health Canada approves Sunshine Biopharma's generic Ondansetron
Jul 28, 2026 08:00AM
Jul 20, 2026 04:28PM
Jul 20, 2026 08:30AM
Jun 25, 2026 08:01AM
Jun 25, 2026 08:00AM
Jun 1, 2026 08:00AM
May 29, 2026 08:01AM Sunshine Biopharma receives patent for coronavirus treatment compounds
May 29, 2026 08:00AM
May 28, 2026 09:00AM
May 28, 2026 09:00AM
May 21, 2026 07:00AM
May 19, 2026 12:09PM
May 19, 2026 12:05PM
May 18, 2026 12:18PM Sunshine Biopharma prices $6 million public offering at $0.50 per unit
May 18, 2026 12:15PM
Apr 6, 2026 08:30AM
Oct 28, 2025 02:10PM
Oct 28, 2025 02:10PM
Oct 28, 2025 07:45AM
Oct 28, 2025 07:45AM
Oct 20, 2025 07:45AM Sunshine Biopharma launches generic doxycycline in Canada
Oct 20, 2025 07:45AM
Oct 16, 2025 07:45AM
Oct 16, 2025 07:45AM
Oct 14, 2025 10:45AM
Oct 14, 2025 08:50AM
Oct 14, 2025 07:03AM
Oct 14, 2025 07:00AM Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
Oct 9, 2025 08:02AM
Oct 9, 2025 08:00AM
Aug 5, 2025 06:04AM
Jul 2, 2025 08:02AM
Jul 2, 2025 08:00AM
Jun 11, 2025 08:34AM
Jun 11, 2025 08:30AM Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
May 15, 2025 04:15PM

468,807 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All